Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at design software stocks, starting with ...

Cognition Therapeutics (NASDAQ:CGTX) executives told investors at the Needham conference that the company is preparing to ...

Dolby Laboratories stock (NYSE: DLB) is up around 35% since the beginning of 2020, and at the current price around $90 per share, we believe that Dolby Laboratories stock has over 15% potential ...

At the International Dementia With Lewy Body Conference, held December 1-4 in Fort Lauderdale, Florida, scientists suggested that concurrent amyloid pathology in DLB explains some of the overlap ...

Dolby Laboratories said on February 2, 2023 that its board of directors declared a regular quarterly dividend of $0.27 per share ($1.08 annualized). Shareholders of record as of February 13, 2023 will ...

Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter ...

Dementia with Lewy bodies, a common but obscure disease, was thrust into public consciousness in 2014 with the suicide of the actor Robin Williams. Now recognized as its own disorder, DLB is difficult ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.